Consolidated Statements of Stockholders' Equity - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Treasury Stock, Common [Member]	Noncontrolling Interest [Member]	Total
Balance at Dec. 31, 2023	$ 2,000	$ 69,779,706	$ 134,666	$ (53,411,295)	$ (99,963)	$ (201,737)	$ 16,203,377
Balance, shares at Dec. 31, 2023	19,994,719
Treasury shares, balance at Dec. 31, 2023					(72,363)
Shares issued under ATM facility for cash proceeds, net of offering costs	$ 7	338,488					338,495
Shares issued under ATM facility for cash proceeds, net of offering costs, shares	68,302
Shares issued under public offering for cash proceeds, net of offering costs	$ 632	15,519,722					15,520,354
Shares issued under public offering for cash proceeds, net of offering costs, shares	6,319,025
Shares issued for exercise of stock options		2,489					$ 2,489
Shares issued for exercise of stock options, shares	1,251						834
Shares issued for services	$ 24	627,352					$ 627,376
Shares issued for services, shares	239,210
Stock-based compensation		2,393,197					2,393,197
Non-controlling interests in subsidiary		29,672				(29,672)
Buyout of non-controlling interests in subsidiary	$ 99	(316,495)				316,396
Buyout of non-controlling interests in subsidiary, shares	989,876
Net loss				(21,613,376)		(84,987)	(21,698,363)
Foreign currency translation adjustment			(135,722)				(135,722)
Balance at Dec. 31, 2024	$ 2,762	88,374,131	(1,056)	(75,024,671)	$ (99,963)		$ 13,251,203
Balance, shares at Dec. 31, 2024	27,612,383
Treasury shares, balance at Dec. 31, 2024					(72,363)		72,363
Shares issued under ATM facility for cash proceeds, net of offering costs	$ 169	4,409,261					$ 4,409,430
Shares issued under ATM facility for cash proceeds, net of offering costs, shares	1,697,504
Shares issued under public offering for cash proceeds, net of offering costs	$ 1,911	93,687,770					93,689,681
Shares issued under public offering for cash proceeds, net of offering costs, shares	19,117,646
Shares issued for exercise of stock options		6,342					$ 6,342
Shares issued for exercise of stock options, shares	4,900						4,900
Shares issued for services	$ 25	508,725					$ 508,750
Shares issued for services, shares	243,670
Stock-based compensation		1,933,125					1,933,125
Net loss				(29,438,613)			(29,438,613)
Foreign currency translation adjustment			61,216				61,216
Shares and warrants issued under private placement for cash proceeds, net of offering costs	$ 392	9,249,844					9,250,236
Shares and warrants issued under private placement for cash proceeds, net of offering costs, shares	3,915,604
Shares issued for exercise of stock warrants	$ 16	124,784					124,800
Shares issued for exercise of stock warrants, shares	156,000
Shares issued for vested restricted stock awards	$ 26	(26)
Shares issued for vested restricted stock awards	275,759
Balance at Dec. 31, 2025	$ 5,301	$ 198,293,956	$ 60,160	$ (104,463,284)	$ (99,963)		$ 93,796,170
Balance, shares at Dec. 31, 2025	53,023,466
Treasury shares, balance at Dec. 31, 2025					(72,363)		72,363

Immix Biopharma, Inc. 10-K